Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

European Journal of Clinical Pharmacology
Florence van HunselKees van Grootheest

Abstract

The aim of this study was to quantify the reasons and opinions of patients who reported adverse drug reactions (ADRs) in the Netherlands to a pharmacovigilance centre. A web-based questionnaire was sent to 1370 patients who had previously reported an ADR to a pharmacovigilance centre. The data were analysed using descriptive statistics, χ(2) tests and Spearman's correlation coefficients. The response rate was 76.5% after one reminder. The main reasons for patients to report ADRs were to share their experiences (89% agreed or strongly agreed), the severity of the reaction (86% agreed or strongly agreed to the statement), worries about their own situation (63.2% agreed or strongly agreed) and the fact the ADR was not mentioned in the patient information leaflet (57.6% agreed or strongly agreed). Of the patient-responders, 93.8% shared the opinion that reporting an ADR can prevent harm to other people, 97.9% believed that reporting contributes to research and knowledge, 90.7% stated that they felt responsible for reporting an ADR and 92.5% stated that they will report a possible ADR once again in the future. The main motives for patients to report their ADRs to a pharmacovigilance centre were the severity of the ADR and their need...Continue Reading

References

Aug 1, 1988·The Journal of Hospital Infection·J Cohen
Mar 1, 1995·British Journal of Clinical Pharmacology·K J BeltonS M Wood
Dec 3, 1999·British Journal of Clinical Pharmacology·I A ElandB H Stricker
Feb 24, 2001·European Journal of Clinical Pharmacology·M BäckströmT Nordkvist-Olsson
Oct 24, 2002·Journal of Clinical Epidemiology·J HasfordB Müller-Oerlinghausen
Jan 1, 1997·Pharmacoepidemiology and Drug Safety·C Biriell, I R Edwards
Jul 23, 2004·Expert Opinion on Drug Safety·Kees van Grootheest, Lolkje de Jong-van den Berg
Sep 4, 2004·BMJ : British Medical Journal·Christian Frankenfeld
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJuan Jesus Gestal-Otero
Feb 4, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cornelis S van der HooftBruno H Ch Stricker
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJ J Gestal-Otero
Sep 6, 2006·Pharmacoepidemiology and Drug Safety·Anne G GranasAnne M Horn
Feb 6, 2007·British Journal of Clinical Pharmacology·A BlenkinsoppP A Routledge
Jul 10, 2007·European Journal of Clinical Pharmacology·Juliet M FosterLolkje de Jong-van den Berg
May 20, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joyce de LangenKees van Grootheest
Jul 8, 2008·European Journal of Clinical Pharmacology·Y ZopfH Dormann
Oct 1, 2008·European Journal of Clinical Pharmacology·Elisabet Ekman, M Bäckström
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
Sep 3, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Anneke PassierEugène van Puijenbroek
Oct 9, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lise AagaardEbba Holme Hansen
Mar 12, 2010·The New England Journal of Medicine·Ethan Basch
Apr 15, 2010·The Annals of Pharmacotherapy·Florence P A M van HunselKees van Grootheest
Apr 24, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeff J GuoDennis W Raisch

❮ Previous
Next ❯

Citations

Apr 22, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Florence Margraff, Delphine Bertram
Aug 7, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G Niklas Norén
Mar 12, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Roberto LeoneGiampaolo Velo
Mar 15, 2015·Expert Opinion on Drug Safety·Leàn RolfesEugène van Puijenbroek
May 20, 2011·Journal of Clinical Pharmacy and Therapeutics·S LorimerN J Langford
Aug 22, 2012·British Journal of Clinical Pharmacology·Janine ArnottBridget Young
Apr 19, 2011·British Journal of Clinical Pharmacology·Claire AndersonUNKNOWN Yellow Card Study Collaboration
Jul 28, 2012·Pharmacoepidemiology and Drug Safety·Linda HärmarkKees van Grootheest
May 6, 2016·Frontiers in Pharmacology·Joëlle BerrewaertsMartin Desseilles
May 26, 2015·European Journal of Clinical Pharmacology·Cristiano MatosJoão Joaquim
Jan 30, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda HärmarkBirgitta Grundmark
Feb 24, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kenneth Hartigan-Go
Feb 18, 2015·Journal of Biomedical Informatics·Ming YangWei Shang
Jan 13, 2015·International Journal of Clinical Pharmacy·Jarernsiripornkul NarumolJanet Krska
May 6, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Leàn RolfesEugène van Puijenbroek
Aug 26, 2016·British Journal of Clinical Pharmacology·Pedro InácioMarja Airaksinen
Nov 12, 2016·European Journal of Clinical Pharmacology·Narumol JarernsiripornkulJanet Krska
Oct 28, 2018·International Journal of Clinical Pharmacy·Sirinya KampichitNarumol Jarernsiripornkul
May 18, 2018·The International Journal of Pharmacy Practice·Esther SalgueiroGloria Manso
Oct 26, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cristiano MatosFlorence van Hunsel
Nov 19, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Heather Draper EppertUNKNOWN American Society of Health-System Pharmacists
May 29, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Cristina RomanBiswadev Mitra
Mar 23, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Ralph Edwards, Marie Lindquist
Jul 15, 2020·European Journal of Clinical Pharmacology·Rania Al DweikDafna Kohen
Nov 22, 2016·British Journal of Clinical Pharmacology·Rania Al DweikSanni Yaya
Jun 28, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·George Tsey SabblahEugène van Puijenbroek
Apr 14, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Leàn RolfesEugène van Puijenbroek
Dec 14, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Florence van HunselKees van Grootheest
Mar 2, 2021·The Lancet. Digital Health·Nabarun DasguptaJohn S Brownstein
May 28, 2021·Research in Social & Administrative Pharmacy : RSAP·Jirunya AssaneeTanattha Kitisopee
Aug 10, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sieta T de VriesUNKNOWN IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4

❮ Previous
Next ❯

Software Mentioned

SurveyMonkey
SPSS Statistics
QSR NVivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacoepidemiology and Drug Safety
Adeline GalliniFrench PharmacoVigilance Network
Pharmacy World & Science : PWS
Kees van GrootheestLolkje T W de Jong-van den Berg
Pharmacoepidemiology and Drug Safety
Marija PetronijevicAyako Suzuki
The International Journal of Pharmacy Practice
Carlos Calderón-Ospina, Carlos Bustamante-Rojas
© 2021 Meta ULC. All rights reserved